scPharmaceuticals Gestion
Gestion contrôle des critères 2/4
Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.
Informations clés
John Tucker
Directeur général
US$1.8m
Rémunération totale
| Pourcentage du salaire du PDG | 32.8% |
| Durée du mandat du directeur général | 7.8yrs |
| Propriété du PDG | 0.2% |
| Durée moyenne d'occupation des postes de direction | pas de données |
| Durée moyenne du mandat des membres du conseil d'administration | 7yrs |
Mises à jour récentes de la gestion
Recent updates
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless
Nov 19
Downgrade: Here's How Analysts See scPharmaceuticals Inc. (NASDAQ:SCPH) Performing In The Near Term
Nov 18Is scPharmaceuticals (NASDAQ:SCPH) Using Too Much Debt?
Jun 27scPharmaceuticals Inc. (NASDAQ:SCPH) Stocks Shoot Up 26% But Its P/S Still Looks Reasonable
Jun 27The scPharmaceuticals Inc. (NASDAQ:SCPH) Full-Year Results Are Out And Analysts Have Published New Forecasts
Mar 16Is scPharmaceuticals (NASDAQ:SCPH) Using Debt Sensibly?
Nov 25scPharmaceuticals: Furoscix Approval A Potential Paradigm Shift For Heart Failure Patients
Oct 20FDA approves scPharmaceuticals Furoscix to treat congestion in heart failure
Oct 10Does scPharmaceuticals (NASDAQ:SCPH) Have A Healthy Balance Sheet?
Jan 11Is scPharmaceuticals (NASDAQ:SCPH) A Risky Investment?
Sep 02scPharmaceuticals: We Still See A High Probability Of Success For FUROSCIX
Aug 26Here's What scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shareholder Ownership Structure Looks Like
Mar 09How Many scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Do Institutions Own?
Nov 24
Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$80m |
| Jun 30 2024 | n/a | n/a | -US$61m |
| Mar 31 2024 | n/a | n/a | -US$58m |
| Dec 31 2023 | US$2m | US$604k | -US$55m |
| Sep 30 2023 | n/a | n/a | -US$50m |
| Jun 30 2023 | n/a | n/a | -US$45m |
| Mar 31 2023 | n/a | n/a | -US$40m |
| Dec 31 2022 | US$2m | US$580k | -US$37m |
| Sep 30 2022 | n/a | n/a | -US$35m |
| Jun 30 2022 | n/a | n/a | -US$31m |
| Mar 31 2022 | n/a | n/a | -US$29m |
| Dec 31 2021 | US$2m | US$550k | -US$28m |
| Sep 30 2021 | n/a | n/a | -US$28m |
| Jun 30 2021 | n/a | n/a | -US$31m |
| Mar 31 2021 | n/a | n/a | -US$32m |
| Dec 31 2020 | US$2m | US$531k | -US$32m |
| Sep 30 2020 | n/a | n/a | -US$35m |
| Jun 30 2020 | n/a | n/a | -US$32m |
| Mar 31 2020 | n/a | n/a | -US$31m |
| Dec 31 2019 | US$1m | US$514k | -US$33m |
| Sep 30 2019 | n/a | n/a | -US$27m |
| Jun 30 2019 | n/a | n/a | -US$27m |
| Mar 31 2019 | n/a | n/a | -US$29m |
| Dec 31 2018 | US$1m | US$494k | -US$29m |
| Sep 30 2018 | n/a | n/a | -US$31m |
| Jun 30 2018 | n/a | n/a | -US$31m |
| Mar 31 2018 | n/a | n/a | -US$28m |
| Dec 31 2017 | US$2m | US$380k | -US$24m |
Rémunération vs marché: La rémunération totale de John ($USD 1.84M ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 1.46M ).
Rémunération et revenus: La rémunération de John a augmenté alors que l'entreprise n'est pas rentable.
PDG
John Tucker (61 yo)
7.8yrs
Titularisation
US$1,838,662
Compensation
Mr. John H. Tucker has been the Chief Executive Officer and President of scPharmaceuticals Inc. (alternate name: scPharmaceuticals LLC) since January 30, 2017 and serves as its Principal Executive Officer...
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | 8.8yrs | US$1.84m | 0.18% $ 303.7k | |
| Independent Director | 9.9yrs | US$184.55k | 0.11% $ 182.4k | |
| Independent Chairman of the Board | 8.4yrs | US$227.05k | 0.010% $ 16.7k | |
| Independent Director | 10.7yrs | US$189.55k | 0% $ 0 | |
| Independent Director | 7yrs | US$187.05k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Independent Director | 3.8yrs | US$182.05k | 0% $ 0 | |
| Independent Director | 6.3yrs | US$187.05k | 0% $ 0 | |
| Independent Director | 6.4yrs | US$197.05k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$187.05k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données |
7.0yrs
Durée moyenne de l'emploi
63yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de SCPH sont considérés comme expérimentés (ancienneté moyenne 7 ans).